Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Nevro Corp (NYSE:NVRO) Receives Average Rating of "Buy" from Brokerages
08:34am, Thursday, 23'rd Apr 2020
Shares of Nevro Corp (NYSE:NVRO) have received an average recommendation of “Buy” from the fourteen analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has ra
Nevro to Report First Quarter 2020 Financial Results
11:00am, Tuesday, 21'st Apr 2020
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its fi
Weekly Investment Analysts' Ratings Updates for Nevro (NVRO)
09:04am, Tuesday, 21'st Apr 2020
A number of firms have modified their ratings and price targets on shares of Nevro (NYSE: NVRO) recently: 4/3/2020 – Nevro had its price target lowered by analysts at Morgan Stanley from $118.00 to
New York, April 17, 2020 -- Reportlinker.com announces the release of the report "Global Deep Brain Stimulation Devices Market By Applications By End User By Region, Industry.
Empowered Funds LLC Takes $906,000 Position in Nevro Corp (NYSE:NVRO)
10:22am, Friday, 17'th Apr 2020
Empowered Funds LLC bought a new stake in shares of Nevro Corp (NYSE:NVRO) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 9,065 shares of the m
Nevro Corp (NYSE:NVRO) Expected to Post Quarterly Sales of $86.63 Million
07:18am, Friday, 17'th Apr 2020
Brokerages expect that Nevro Corp (NYSE:NVRO) will announce sales of $86.63 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Nevro�
Exchange Traded Concepts LLC Increases Stake in Nevro Corp (NYSE:NVRO)
09:34am, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC grew its position in shares of Nevro Corp (NYSE:NVRO) by 48.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,
Liberty All-Star Growth Fund, Inc. March 2020 Monthly Update
09:59pm, Wednesday, 15'th Apr 2020
Below is the March 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG)
Nevro Corp:
Nevro prevails in patent dispute with Boston Scientific
02:05pm, Friday, 10'th Apr 2020
In a unanimous opinion, an appeals court ruled in favor of all of Nevro's (NYSE:NVRO) asserted claims covering methods and systems for delivering spinal cord stimulation (SCS) therapy at high
Alliancebernstein L.P. Has $5.14 Million Holdings in Nevro Corp (NYSE:NVRO)
08:18am, Friday, 10'th Apr 2020
Alliancebernstein L.P. boosted its stake in shares of Nevro Corp (NYSE:NVRO) by 4.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commiss
IN BRIEF: Fed Circuit restores Nevro patents on spinal-cord stimulation
01:37am, Friday, 10'th Apr 2020
The U.S. Court of Appeals for the Federal Circuit on Thursday revived Nevro Corp’s lawsuit against Boston Scientific over four patents for producing electronic spinal-cord stimulation (SCS) without
Nevro says court upholds patent claims validity in Boston Scientific case NVRO;BSX
05:15pm, Thursday, 09'th Apr 2020
Nevro says court upholds patent claims validity in Boston Scientific case NVRO BSX
BRIEF-Nevro Says Its Patent Litigation Against Boston Scientific U.S. Court Of Appeals For Federal Circuit Issued A Ruling In Its Favor
05:07pm, Thursday, 09'th Apr 2020
Nevro Corp:
